Di Carlo E - Search Results

1

Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/MyD88 pathway.

Andreuzzi E, Fejza A, Polano M, Poletto E, Camicia L, Carobolante G, Tarticchio G, Todaro F, Di Carlo E, Scarpa M, Scarpa M, Paulitti A, Capuano A, Canzonieri V, Maiero S, Fornasarig M, Cannizzaro R, Doliana R, Colombatti A, Spessotto P, Mongiat M. Andreuzzi E, et al. Among authors: di carlo e. J Exp Clin Cancer Res. 2022 Feb 11;41(1):60. doi: 10.1186/s13046-022-02271-y. J Exp Clin Cancer Res. 2022. PMID: 35148799 Free PMC article.

2

Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis.

Sangaletti S, Di Carlo E, Gariboldi S, Miotti S, Cappetti B, Parenza M, Rumio C, Brekken RA, Chiodoni C, Colombo MP. Sangaletti S, et al. Among authors: di carlo e. Cancer Res. 2008 Nov 1;68(21):9050-9. doi: 10.1158/0008-5472.CAN-08-1327. Cancer Res. 2008. PMID: 18974151

3

Interleukin-30 Promotes Breast Cancer Growth and Progression.

Airoldi I, Cocco C, Sorrentino C, Angelucci D, Di Meo S, Manzoli L, Esposito S, Ribatti D, Bertolotto M, Iezzi L, Natoli C, Di Carlo E. Airoldi I, et al. Among authors: di meo s, di carlo e. Cancer Res. 2016 Nov 1;76(21):6218-6229. doi: 10.1158/0008-5472.CAN-16-0189. Epub 2016 Aug 22. Cancer Res. 2016. PMID: 27550449

4

Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization.

Sorrentino C, Ciummo SL, Cipollone G, Caputo S, Bellone M, Di Carlo E. Sorrentino C, et al. Among authors: di carlo e. Cancer Res. 2018 May 15;78(10):2654-2668. doi: 10.1158/0008-5472.CAN-17-3117. Epub 2018 Feb 27. Cancer Res. 2018. PMID: 29487200

5

Decoding the Role of Interleukin-30 in the Crosstalk Between Cancer and Myeloid Cells.

Di Carlo E. Di Carlo E. Cells. 2020 Mar 4;9(3):615. doi: 10.3390/cells9030615. Cells. 2020. PMID: 32143355 Free PMC article. Review.

6

Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways.

Ciummo SL, Sorrentino C, Fieni C, Di Carlo E. Ciummo SL, et al. Among authors: di carlo e. J Exp Clin Cancer Res. 2023 Dec 12;42(1):336. doi: 10.1186/s13046-023-02902-y. J Exp Clin Cancer Res. 2023. PMID: 38087324 Free PMC article.

7

Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice.

Nanni P, Nicoletti G, De Giovanni C, Croci S, Astolfi A, Landuzzi L, Di Carlo E, Iezzi M, Musiani P, Lollini PL. Nanni P, et al. Among authors: di carlo e. Cancer Res. 2003 Jun 1;63(11):2728-32. Cancer Res. 2003. PMID: 12782574

8

Immunological prevention of a multigene cancer syndrome.

Croci S, Nicoletti G, Landuzzi L, De Giovanni C, Astolfi A, Marini C, Di Carlo E, Musiani P, Forni G, Nanni P, Lollini PL. Croci S, et al. Among authors: di carlo e. Cancer Res. 2004 Nov 15;64(22):8428-34. doi: 10.1158/0008-5472.CAN-04-2341. Cancer Res. 2004. PMID: 15548714

9

Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype.

Sorrentino C, Di Carlo E. Sorrentino C, et al. Among authors: di carlo e. Am J Respir Crit Care Med. 2009 Oct 15;180(8):769-79. doi: 10.1164/rccm.200903-0400OC. Epub 2009 Jul 23. Am J Respir Crit Care Med. 2009. PMID: 19628777

10

Androgen deprivation boosts prostatic infiltration of cytotoxic and regulatory T lymphocytes and has no effect on disease-free survival in prostate cancer patients.

Sorrentino C, Musiani P, Pompa P, Cipollone G, Di Carlo E. Sorrentino C, et al. Among authors: di carlo e. Clin Cancer Res. 2011 Mar 15;17(6):1571-81. doi: 10.1158/1078-0432.CCR-10-2804. Epub 2010 Dec 15. Clin Cancer Res. 2011. PMID: 21159885

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page